financetom
Business
financetom
/
Business
/
Update: Market Chatter: Chinese Tech Giants Turn to Local AI Chips Instead of Nvidia Due to US Restrictions
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Market Chatter: Chinese Tech Giants Turn to Local AI Chips Instead of Nvidia Due to US Restrictions
May 30, 2025 6:52 AM

09:15 AM EDT, 05/30/2025 (MT Newswires) -- (Updates with Nvidia's ( NVDA ) declining to comment in fifth paragraph.)

Alibaba ( BABA ) , Baidu ( BIDU ) , and other Chinese tech giants are aiming to shift toward domestic AI chips instead of Nvidia ( NVDA ) due to tightened US export controls, the Financial Times reported Thursday, citing industry executives.

The ban on Nvidia's ( NVDA ) H20 chips has reportedly accelerated efforts to adopt local alternatives, with current stockpiles expected to last only until early 2026.

Switching ecosystems may delay AI development by around three months due to software compatibility issues, the FT quoted an executive as saying.

Nvidia ( NVDA ) may deliver a compliant chip for China by July, but it will lack key features like high-bandwidth memory, the news outlet reported.

Nvidia ( NVDA ) declined to comment when reached by MT Newswires.

Alibaba ( BABA ) and Baidu ( BIDU ) did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Palantir Technologies Shares Today?
What's Going On With Palantir Technologies Shares Today?
Jun 28, 2024
Palantir Technologies Inc. ( PLTR ) shares are trading marginally higher on Friday. Peter Thiel, Chairman of Palantir Technologies ( PLTR ), shared his outlook on the future in an NBC News interview. He focused on AI, digital currencies, and his views on America’s current state. In an interview with BNN Bloomberg, Dan Ives, an analyst at Wedbush Securities, dismissed the notion...
Mirum Pharmaceuticals Submits New Drug Application for Cholesterol Metabolism Treatment
Mirum Pharmaceuticals Submits New Drug Application for Cholesterol Metabolism Treatment
Jun 28, 2024
10:34 AM EDT, 06/28/2024 (MT Newswires) -- Mirum Pharmaceuticals ( MIRM ) said Friday that it has submitted a new drug application for chenodiol for treating patients with cerebrotendinous xanthomatosis, or CTX, in the US. CTX is a rare progressive disorder of cholesterol metabolism that can affect the brain, spinal cord, tendons, eyes, and arteries, the company said. The submission...
Rhythm Pharmaceuticals Says EMA Committee Backs Expanded Authorization for Obesity Drug
Rhythm Pharmaceuticals Says EMA Committee Backs Expanded Authorization for Obesity Drug
Jun 28, 2024
10:35 AM EDT, 06/28/2024 (MT Newswires) -- Rhythm Pharmaceuticals ( RYTM ) said Friday it had received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use, recommending an expanded marketing authorization for Imcivree to include children between 2 and 6 years old with neuroendocrine diseases. The company said it expects a decision from the...
Onex Partners Completes Acquisition of Accredited
Onex Partners Completes Acquisition of Accredited
Jun 28, 2024
10:30 AM EDT, 06/28/2024 (MT Newswires) -- Onex Partners (ONEX.TO) said Friday it has completed its acquisition of Accredited, a global P&C program manager. A statement noted Accredited will now operate as an independent program management company providing A- rated (AM Best) insurance capacity in Europe, the UK and the US. Accredited writes more than $2.1 billion of gross premium...
Copyright 2023-2026 - www.financetom.com All Rights Reserved